RHB Banking Group has introduced RHB Wealth Advance (RWA) and Takaful mySmart Income Enhanced (MSIE), combining investment, protection, and income features to support customers across different life stages and financial priorities.
Australian life insurers have welcomed the passage of a new law that bans genetic discrimination and gives people confidence on genetic testing.
The Thai insurance regulator, Office of the Insurance Commission (OIC), aims to build a private health insurance system that can perform the role of a health partner, and accelerate the expansion of the insured base and control system costs in the country.
Insurers in South Korea are expanding their range of children's insurance products as they look to rope in customers for the long-term.
The Saudi insurance industry's profits (after zakat & tax) declined significantly by 36% year-on-year to SAR2.0bn ($533m) in 2025 from SAR3.2bn in 2024, according to BADRI Management Consultancy, an international actuarial and risk management consulting firm.
China Reinsurance (Group) Co [China Re Group] has posted consolidated insurance revenue of CNY103.1bn for 2025, 1.7% higher than in 2024. Consolidated total premium income reached CNY180.4bn, a year-on-year increase of 1.1%, according to the company's consolidated financial statements.
The Insurance Association of China (IAC) has published the "Self-Regulatory Code of Conduct for the Management of Insurance Product Suitability".
One major area of abuse of medical insurance funds is the resale of drugs and medical consumables, where unscrupulous medical institutions induce individuals to purchase these items and then resell them, according to Mr Gu Rong, Director of the Fund Supervision Department of the National Healthcare Security Administration (NHSA).
Ping An Insurance (Group) Company of China {Ping An Group] has reported that its operating profit after tax attributable to shareholders of the parent company was CNY134.4bn ($19.5bn) in 2025, up by 10.3% year on year.
New China Insurance (NCI), one of China's biggest listed life insurers, has reported a net profit attributable to shareholders of CNY36.3bn ($5.3bn) in 2025, a year-on-year increase of 38.3%.